Introduction
Malaria is an infectious disease caused by protozoa of the genus Plasmodium and transmitted by the Anopheles mosquito. Among the four pathogenic species, Plasmodium falciparum is the most dangerous one. Although this disease can be prevented and treated, it still kills more than one million people each year.
1 A major problem is the increasing resistance of the parasite against the currently available drugs, hence the continuous need for new and more effective antiplasmodial drugs.
Within the scope of the battle against malaria, several alkaloids have been isolated from Cryptolepis sanguinolenta, a plant used in Central and West African traditional folk medicine to treat fevers caused by malaria. Among these isolated alkaloids are cryptolepine 2a (5-methyl-5H-indolo[3,2-b]quinoline) (1), neocryptolepine 2b,2c (cryptotackieine, 5-methyl-5H-indolo[2, 3- b]quinoline) (2) and isocryptolepine 2d,2e (cryptosanguinolentine, 5-methyl-5H-indolo [3,2-c] quinoline) (3) (Fig. 1) . The benzo-β-carboline (5-methyl-5H-indolo[2, 3-c] quinoline, for which we have adopted the name isoneocryptolepine) (4), surprisingly has not yet been found in nature. 3, 4 The alkaloids 1-4 are isomeric indoloquinolines which possess interesting antiplasmodial activities. The "missing" isomer isoneocryptolepine (4) has the best selectivity index (SI = cytotoxicity/antiplasmodial activity ratio) of the four indoloquinolines (Table 1) The SI of 4 stimulated us to synthesise new unnatural indoloquinoline isomers. Recently, we described the synthesis and biological evaluation of the indoloisoquinolines 6-methyl-6H-indolo[3,2-c]isoquinoline (5) and 6-methyl-6H-indolo[2, 3-c] isoquinoline (6) , which are the isoquinoline analogues of respectively 3 and 4 ( Fig. 1) . 6 Inspired by the initial results of the team of Quéguiner for cryptolepine 7 , we recently started exploring the effect of A and D-ring stripping on the SI in the cryptolepine series. 8 In this article, we describe the synthesis of 5-methyl-5H-pyrrolo[2,3-c]quinoline (7) and 4-methyl-4H-pyrrolo[2, 3-c] isoquinoline (8) , D-ring debenzo analogues of respectively 4 and 6 (Fig. 1) . A wide range of strategies can be used to synthesize azaindoles, e.g. Reissert, Madelung, Batcho-Leimgruber, Hemetsberger-Knittel and Bartoli synthesis. 9 Besides these classical approaches, also strategies based on organometals have been used. 9 The classical approaches are often lengthy procedures, require sometimes harsh reaction conditions and result often in poor yields. This, together with the previous work of our laboratory in the area of azaheteroaromatic scaffold construction via Pd catalysis, made us wonder whether the benzoazaindole core skeleton of 7 and 8 could be synthesized via a Pd-catalyzed annulation reaction. 10 To the best of our knowledge these cores (9 and 12) have not yet been reported.
Results and Discussion
In order to synthesize 3H-pyrrolo[2,3-c]quinoline (9) and 3H-pyrrolo[2, 3-c] isoquinoline (12), the cores of 7 and 8, via a Pd-catalyzed annulation approach a halogenated quinoline and isoquinoline precursor were required (Scheme 1). Brominated compounds 4-bromoquinolin-3-amine (10) and 4-bromoisoquinolin-3-amine (13) were chosen as precursors since the latter was already available in our lab. 13 was prepared via bromination of commercially available isoquinolin-3-amine (14) with NBS in methanol at room temperature. The reaction time could be diminished from 1 hour to 5 minutes by adding 0.1 mol% NH 4 OAc to the reaction and using CH 3 CN as the solvent (Scheme 2). 6, 11 This optimized bromination procedure also worked smoothly for the synthesis of 4-bromoquinolin-3-amine (10) starting from commercially available quinolin-3-amine (11) (Scheme 2). Scheme 2. Synthesis of 4-bromoquinolin-3-amine (10) and 4-bromoisoquinolin-3-amine (13) via bromination.
For the Pd-catalyzed annulation, the reaction conditions reported by Jia and Zhu were initially selected [1 equiv aldehyde, 3 equiv KOAc, 5 mol% Pd(dba) 2 /10 mol% X-Phos, DMA, oil bath, 120 ºC]. 10a These were developed for the synthesis of C-3 substituted indoles starting from ortho-bromoanilines or ortho-chloroanilines and aldehydes. DMA was substituted for DMF by us as the latter is readily commercially available as an extra dry solvent. Optimization of the reaction conditions, allowing the use of this low boiling and sensitive aldehyde, revealed that the use of a dehydrating agent as well as a higher amount of acetaldehyde significantly shortened the required reaction time. The effect of the excess of the aldehyde can be rationalized if one takes into account the ease of its trimerization and its very low boiling point. In both cases reagent is lost; in the former case via trimer formation (the reaction temperature of the annulation is 120 °C), in the latter via evaporation (only a reflux condenser with standard water cooling was used). Therefore, the Pd-catalyzed annulations were always performed with a large excess (5 mL) of freshly distilled acetaldehyde to ensure there is enough monomeric acetaldehyde present for the initial condensation. Systematic lowering of the catalyst loading showed that the reaction could be driven to completion within 1 hour of stirring at 120 °C with a 2 mol% catalyst loading. These optimized reaction conditions [5 mL (89 mmol) aldehyde, 3 equiv KOAc, 2 mol% Pd(dba) 2 /4 mol% X-Phos, DMF, oil bath, 120 ºC] gave hitherto unknown 3H-pyrrolo[2,3-c]quinoline (9) in an excellent 98% yield (Scheme 3). Similarly, 3H-pyrrolo[2,3-c]isoquinoline (12) could also be synthesised via this optimized procedure, but a catalyst loading of 1 mol% nor 2 mol% was sufficient to obtain full conversion in a reaction time of 1 hour. 10 mol% was found to be able to drive the reaction to completion in 1 hour (Scheme 3). No catalyst loading between 2 and 10 mol% was tested for substrate 13. Generally, lower loadings (e.g. 2 mol%) can be used if one takes into account a longer reaction time together with adding extra acetaldehyde in portions during the reaction. Presumably the decreased reactivity of 13 is due to the lower nucleophilicity of the amino group in comparison with 10 providing less enamine intermediate for the subsequent Heck cyclisation. Selective methylation of 9 and 12 at N-5 and N-4, respectively, was performed under our previously reported reaction conditions (CH 3 I, THF, reflux; then 28-30% NH 3 in H 2 O) for the selective methylation of indoloquinolines (Scheme 4). 4, 6 Dimethylation can be avoided because the formed hydroiodide salts 7.HI and 8.HI precipitate from the reaction mixture. A reaction time of 2 hours was necessary to obtain full conversion of 9 to 7.HI and 12 to 8.HI. The free bases 7 and 8 can be easily obtained from 7.HI and 8.HI in respectively 80% and 93% yield after an acid-base extraction using ammonia in water (28-30%). 
Conclusions
In conclusion, we synthesized two new unnatural isomers of the cryptolepine series: 5-methyl-5H-pyrrolo[2,3-c]quinoline (7) and 4-methyl-4H-pyrrolo[2, 3-c] isoquinoline (8) . These compounds and their core skeletons have, to the best of our knowledge, never been synthesized before. 3H-Pyrrolo[2,3-c]quinoline (9) and 3H-pyrrolo[2,3-c]isoquinoline (12) were obtained via a Pd-catalyzed annulation, starting from respectively 4-bromoquinolin-3-amine (11) and 4-bromoisoquinolin-3-amine (14). Interestingly, these represent the first examples of annulation of a pyrrole ring on a quinoline and isoquinoline via a domino condensation -Heck cyclisation. In addition, the use of acetaldehyde has not been reported so far. Selective methylation of the basic skeletons 9 and 12 yielded the target compounds 7 and 8 in respectively 69% and 40 % overall yield.
Experimental Section
General Procedures. All melting points were determined on a Büchi apparatus and are uncorrected. The 1 H and 13 C NMR spectra were recorded on a Bruker spectrometer Avance 400
in the solvent indicated with TMS as an internal standard. All coupling constants are given in Hertz and chemical shifts are given in parts per million. The assignment of the 1 H NMR signals of all products is based on 2D NMR techniques (COSY, NOESY, HMQC and HMBC). For mass spectrometric analysis, samples were dissolved in CH 3 OH containing 0.1% formic acid and diluted to a concentration of approximately 10 -5 mol/L. Injections (10 µL) were directed to the mass spectrometer at a flow rate of 0.7 mL/min (CH 3 OH and 0.1% formic acid), using a Kontron HPLC system. Mass spectrometric data were acquired on an AQA Navigator mass spectrometer (ThermoQuest, Finigan) equipped with an ApCI ionisation interface. The AQAMax voltage was set to 20 V, the corona voltage to 3.5 kV and the probe temperature to 250 °C. Nitrogen gas was used for nebulation. Mass spectra were acquired by summing the spectra in the elution plug. ) were used as lock mass. Quinolin-3-amine, isoquinolin-3-amine, CH 3 CN (HPLC grade), DMF (99.85%, water <50 ppm, extra dry over molecular sieve), THF (99.85%, water <50 ppm, extra dry over molecular sieve) and MeI were obtained from Acros. Pd(dba) 2 and XPhos were obtained from Sigma-Aldrich. NBS, NH 4 OAc and paraldehyde were bought from Merck. NBS was recrystallized from water (10 g NBS in 100 mL water). Acetaldehyde was freshly depolymerized from paraldehyde (5 drops of H 2 SO 4 / 10 mL paraldehyde) before use. Flash column chromatography was performed on Kieselgel 60 (ROCC, 0.040-0.063 mm).
General bromination procedure. To a mixture of amine 11 or 14 (0.865 g, 6.0 mmol) and NH 4 OAc (0.046 g, 0.6 mmol) in CH 3 CN (12 mL) was added dropwise a solution of NBS (1.121 g, 6.3 mmol) in CH 3 CN (8 mL). The reaction mixture was stirred at room temperature for 5 min. The solvent was evaporated under reduced pressure and the reaction product was purified by recrystallization from water. 4-Bromoquinolin-3-amine (10). Yield 88%; white to off-white powder; mp 140-142 °C; δ H (CDCl 3 ): 8.48 (s, 1H, H-2), 7.99-7.95 (m, 2H, H-5 and H-8), 7.55 (ddd, J = 8.2, 6.9, 1.3 Hz, 1H,  H-6 or H-7), 7.49 (ddd, J = 8.1, 6.9, 1.3 Hz, 1H, H-6 or H-7 6 . The characterization data are identical to those previously reported by us in the literature. General selective methylation procedure. In a round-bottomed flask pyrrolo(iso)quinoline (9 or 12) (0.084 g, 0.5 mmol), dry THF (7.5 mL) and CH 3 I (3 mL) were heated at reflux under N 2 atmosphere (oil bath temperature: 80 °C) for 2 hours under magnetic stirring. Then the solvent was evaporated to dryness under reduced pressure and the crude product was mixed with silica and purified by flash column chromatography on silica gel using CH 2 Cl 2 /MeOH (90/10) as the eluent yielding pyrrolo(iso)quinoline hydroiodide (7.HI or 8.HI) as a yellow product. To obtain the free base, the salt was brought in a mixture of CH 2 Cl 2 (100 mL) and 28-30% ammonia in water (100 mL). The organic phase was separated and the aqueous phase was subsequently extracted with CH 2 Cl 2 (4 x 25 mL). The combined organic phase was dried over MgSO 4 , filtered and evaporated to dryness. 
